z-logo
open-access-imgOpen Access
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
Author(s) -
Alessandra Mangia,
Valeria Piazzolla,
A. Giannelli,
Egidio Visaggi,
Nicola Minerva,
Vincenzo Palmieri,
I. Carraturo,
Domenico Potenza,
Nicola Napoli,
Gianfranco Lauletta,
Vincenzo Tagarielli,
Rosanna Santoro,
Ernesto Piccigallo,
Sergio De Gioia,
Angelo Chimenti,
Giuseppe Cuccorese,
Antonio Metrangolo,
Michele Mazzola,
Ernesto Agostinacchio,
Giuseppe Mennea,
Carlo Sabbà,
Marina Cela,
Massimiliano Copetti,
R. Losappio
Publication year - 2019
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0223287
Subject(s) - sofosbuvir , medicine , stage (stratigraphy) , fibrosis , gastroenterology , virology , biology , hepatitis c virus , ribavirin , virus , paleontology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here